Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 10/20 | 0.53 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27315456 | 0.94 | IDO1 (0.53) | SIGMAR1IDO1BCHE | |
| SCHEMBL336981 | 0.86 | CA2 (0.47) | SIGMAR1IDO1 | |
| SCHEMBL8369238 | 0.83 | EPHX2 (0.50) | SIGMAR1L3MBTL1MAOA | |
| SCHEMBL22472264 | 0.83 | EPHX2 (0.50) | SIGMAR1L3MBTL1MAOA | |
| SCHEMBL28504289 | 0.83 | EPHX2 (0.50) | SIGMAR1L3MBTL1MAOA | |
| SCHEMBL14144825 | 0.81 | HRAS (0.41) | SIGMAR1IDO1MAOA | |
| SCHEMBL14144826 | 0.81 | DRD4 (0.42) | IDO1MAOABCHE | |
| SCHEMBL5501337 | 0.81 | ALDH1A1 (0.47) | SIGMAR1L3MBTL1 | |
| SCHEMBL27481442 | 0.80 | SIGMAR1 (0.54) | SIGMAR1L3MBTL1 | |
| SCHEMBL5532769 | 0.79 | SIGMAR1 (0.53) | SIGMAR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1030415-A | Saturated heterocycle carboxamide derivatives and its preparation method | YAMANOUCHI PHARMA CO LTD (JP) | 1989-01-18 | — | — | CN | disclosed |
| EP-0279681-A2 | Saturated heterocyclic carboxamide derivatives | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1988-08-24 | — | — | EP | disclosed |